Editorial: Cannabinoids as potential treatment for neurological diseases

Editorial: Cannabinoids as potential treatment for neurological diseases

Bibliographic Details
Main Authors:	María Gómez-Cañas, Paula Morales, Valentina Satta, Carmen Rodríguez-Cueto, Concepción García, Onintza Sagredo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Neuroscience
Subjects:	neurological diseases cannabinoid endocannabinoid system neuroprotection drug discovery
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2022.1108101/full

Similar Items

Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets
by: María Gómez-Ruiz, et al.
Published: (2019-04-01)

Therapeutic Potential of Cannabinoids in Glaucoma
by: Theresa Lindner, et al.
Published: (2023-08-01)

EXPLORING THE MYELINATION STATUS IN A MURINE MODEL OF DRAVET SYNDROME
by: Valentina Satta, et al.
Published: (2023-10-01)

Role of integrating cannabinoids and the endocannabinoid system in neonatal hypoxic-ischaemic encephalopathy
by: Jie Xiao, et al.
Published: (2023-04-01)

ANALYZING THE INFLUENCE OF CANNABIS SATIVA COMPOUNDS ON THE MYELINATION PROCESS IN A MURINE MODEL OF DRAVET SYNDROME
by: Álvaro Sierra Tarazona, et al.
Published: (2023-10-01)

A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders
by: María S. García-Gutiérrez, et al.
Published: (2025-03-01)

Breve reseña sobre la farmacología de los cannabinoides
by: José Ramón Pascual Simón, et al.

Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology
by: Sonia Maria Dozzi BRUCKI, et al.
Published: (2021-06-01)

The Impact of the CB<sub>2</sub> Cannabinoid Receptor in Inflammatory Diseases: An Update
by: Volatiana Rakotoarivelo, et al.
Published: (2024-07-01)

THE EFFICACY OF COMBINED TREATMENT WITH ΒETA-CARYOPHYLLENE AND CANNABIDIOL IN A MOUSE MODEL OF DRAVET SYNDROME
by: José Antonio Guimaré Ortiz, et al.
Published: (2023-10-01)

Investigation in blood-brain barrier integrity and susceptibility to immune cell penetration in a mouse model of Dravet syndrome
by: Cristina Alonso, et al.
Published: (2025-03-01)

The effect of cannabinoids on wound healing: A review
by: Aniruddha C. Parikh, et al.
Published: (2024-02-01)

Impact of the mouse estrus cycle on cannabinoid receptor agonist‐induced molecular and behavioral outcomes
by: Hye Ji J. Kim, et al.
Published: (2022-06-01)

Effects of cannabinoids on ligand-gated ion channels
by: Murat Oz, et al.
Published: (2022-10-01)

Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms
by: Nuchjira Takheaw, et al.
Published: (2023-03-01)

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
by: Ahmed Hasbi, et al.
Published: (2023-02-01)

The Skin and Natural Cannabinoids–Topical and Transdermal Applications
by: Silviu-Iulian Filipiuc, et al.
Published: (2023-07-01)

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
by: Laura Orsolini, et al.
Published: (2019-08-01)

Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
by: Irene Santos-García, et al.
Published: (2023-05-01)

Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy
by: Victor Voicu, et al.
Published: (2023-09-01)

Cannabis medicinal: puntos críticos para su uso clínico
by: Diego Mauricio Gómez-García, et al.
Published: (2022-09-01)

Cannabinoids and the endocannabinoid system in liver diseases
by: Anna Parfieniuk-Kowerda, et al.
Published: (2024-12-01)

Influence of the Synthetic Cannabinoid Agonist on Normal and Inflamed Cartilage: An In Vitro Study
by: Jiangyinzi Shang, et al.
Published: (2023-10-01)

Cannabinoids and COVID-19
by: Myriam El Biali, et al.
Published: (2020-08-01)

Interplay between cannabinoids and the neuroimmune system in migraine
by: Erik Zorrilla, et al.
Published: (2024-10-01)

The role of cannabinoids in pain modulation in companion animals
by: Agatha Miranda-Cortés, et al.
Published: (2023-01-01)

Dual Cannabinoid and Orexin Regulation of Anhedonic Behaviour Caused by Prolonged Restraint Stress
by: Hye Ji J. Kim, et al.
Published: (2023-02-01)

The impact of phyto- and endo-cannabinoids on central nervous system diseases：A review
by: Shan-Shan Zhang, et al.
Published: (2023-01-01)

Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
by: Sonia Burgaz, et al.
Published: (2021-12-01)

Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
by: Robert Ramer, et al.
Published: (2022-12-01)

Components of the Endogenous Cannabinoid System as Potential Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome
by: Saki Sultana, et al.
Published: (2021-12-01)

Cannabis, Cannabinoids, and Stroke: Increased Risk or Potential for Protection—A Narrative Review
by: Caroline Carter, et al.
Published: (2024-04-01)

Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified In Vitro Model
by: Erika Cottone, et al.
Published: (2021-03-01)

The Relationship between Muscarinic and Cannabinoid Receptors in Neuronal Excitability and Epilepsy: A Review
by: Ryan Renaldo Hall, et al.
Published: (2024-05-01)

Cannabinoid CB2 receptors and spinal microglia are implicated in tingenone-mediated antinociception in mice
by: Clarice C.V. Moura, et al.
Published: (2021-01-01)

Effects of cannabinoid and vanilloid receptor antagonists on nicotine induced relaxation response enhancement in rabbit corpus cavernosum
by: İsmail Mert Vural, et al.
Published: (2022-04-01)

Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?
by: Arailym Sarsembayeva, et al.
Published: (2023-11-01)

The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
by: Wujood Khayat, et al.
Published: (2022-06-01)

Cannabinoid type-1 receptors in CaMKII neurons drive impulsivity in pathological eating behavior
by: Elena Martin-Garcia, et al.
Published: (2025-02-01)

Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
by: Attila Oláh, et al.
Published: (2017-11-01)